| Literature DB >> 12121502 |
Abstract
Type 1 hepatorenal syndrome (HRS) is a severe complication of end-stage cirrhosis. Type 1 HRS is an acute functional renal failure (i.e. glomerular hypofiltration) with no other explanation than the presence of the circulatory and neurohumoral alterations associated with severe chronic liver disease. Plasma volume expansion does not improve renal function. In contrast, administration of the vasopressin analog terlipressin, a splanchnic and systemic vasoconstrictor, may improve renal function and be used while awaiting liver transplantation. Copyright 2002 Blackwell Publishing Asia Pty LtdEntities:
Mesh:
Substances:
Year: 2002 PMID: 12121502 DOI: 10.1046/j.1440-1746.2002.02778.x
Source DB: PubMed Journal: J Gastroenterol Hepatol ISSN: 0815-9319 Impact factor: 4.029